What's in Ascendis Pharma A/S's pipeline?

Ascendis Pharma A/S has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ascendis Pharma A/S's portfolio?

Top competitors by shared drug class: Changchun GeneScience Pharmaceutical Co., Ltd., Dong-A ST Co., Ltd., Theratechnologies, Xiamen Amoytop Biotech Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ascendis-pharma-a-s.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Ascendis Pharma A/S — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ascendis Pharma A/S pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
TransCon hGH	TransCon hGH	phase 3	Growth hormone analog	Human growth hormone receptor	Endocrinology

Therapeutic area mix

Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Changchun GeneScience Pharmaceutical Co., Ltd. · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Theratechnologies · 1 shared drug class
Xiamen Amoytop Biotech Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ascendis Pharma A/S:

Cite this brief

Drug Landscape (2026). Ascendis Pharma A/S — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ascendis-pharma-a-s. Accessed 2026-06-10.